Neurorescue and DHA on a 6OHDA preclinical Parkinson model

Neurorescue and DHA on a 6OHDA preclinical Parkinson model

25 Jan Neurorescue and DHA on a 6OHDA preclinical Parkinson model

Preclinical data collected in models of preclinical Parkinson disease (PD) support the neuroprotective potential of omega-3 polyunsaturated fatty acids (n-3 PUFA)-enriched diet on the dopaminergic (DAergic) system. In this study, we investigated the effects of a n-3 PUFA rich diet using a neurorescue/neurorestorative paradigm. C57BL/6 adult mice were submitted to a striatal stereotaxic injection of the neurotoxin 6-hydroxydopamine (6-OHDA) to induce DAergic denervation and subsequent nigral DAergic cell loss. Three weeks post-lesion, mice received either a docosahexaenoic acid (DHA)-enriched or a control diet for a period of 6 weeks. HPLC analyses revealed a 52 % post-lesion increase in striatal dopamine levels in the DHA-fed animals compared to controls (ctrl, P